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1. Introduction 
Heparin and heparan sulphate chains have a 
common carbohydrate backbone composed of 
alternating &D(or o-L) uromc acid and o-D-glucosarnrne 
resrdues Joined 1 + 4. However, heparin is a potent 
anticoagulant while heparan sulphates have little or 
no activity [ 11. The chemical distmction between the 
two glycans is based on differences in 0- and N-sulphate 
content, m the ratio and drstributron of N-acetyl and 
N-sulphate groups and m the Liduronic acid to 
D-glucuronic acid ratio [2,3]. The anticoagulant 
activity of heparm appears to depend on chamlength, 
the distnbution of N-sulphate groups and a high 
degree of 0-sulphation [4]. The followmg requirements 
have been proposed: 
(i) Molecular weight > 6000; 
(ri) N-sulphate to N-acetyl ratio >l provided that 
blocks of N-acetylglucosamine-uranic c d 
repeats are absent from the intenor of the 
molecule, 
(in) 0-Sulphate to hexosamme ratio >l , 
(IV) L-Iduromc acid content >50% of total uromc acrd. 
It is generally assumed that 0-sulphated Liduronic 
acid resrdues are essential for biologrcal activity [ 11. 
These residues occur only m single sequences in
heparan sulphate while heparin may contarn up to 
5 or 6 such units in consecutive order [2]. 
This work was imtlated during a sabbatical (by L -A F 1 at 
the Department of Biological Sciences, Umverslty of 
Lancaster, Lancaster, England 
Heparm impedes blood coagulation by accelerating 
the reaction between antithrombin and serme 
proteases involved in the coagulation cascade [S]. 
With regard to their affimty for antithrombm 
commercial heparm preparations may be separated 
into hrgh affinity (HA) and low affinity (LA) species 
with spec. act. -20 and -280 BP umts/mg [6,7]. No 
apparent structural drssmularity between the two 
heparm forms has been noted. An ohgosacchande 
fraction thought o represent the antrthrombm- 
bmdmg site of heparin was Isolated after digestion of 
the HA-hepann-antithrombm complex with bacterial 
heparmase [ 81. 
The gross cornpositron of this fragment was similar 
to that of the rest of the molecule. More recently, a 
‘highly actrve’ heparm preparation representmg 8% of 
a commercral source and wrth spec. act. 360 BP units/ 
mg has been isolated [9]. Tlus material contams a 
tetrasacchande s quence composed of equivalent 
amounts of Lrduromc acid, D-glucuromc acid, 
N-acetylglucosamine and N-sulphated glucosamme. 
Since this sequence 1s present in submolar proportrons 
m ‘relatively inactive’ preparations it has been 
proposed that rt represents a cntical structural 
element requrred for anticoagulant activrty. 
Periodate oxidation of heparin-related molecules 
at low pH and temperature selectively oxidizes 
D-glucuromc acid associated withN-acetylglucosamme 
unrts [lo] This report describes some preliminary 
studres using penodate oxidation as a probe for the 
elucidation of the structure-functron relatronshrps of 
heparm. 
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2. Materials and methods % 
The heparm used was of mucosal ongm (Evans 
Medical Ltd, Liverpool, batch 5 H 488) and had an 
anticoagulant activity of 157 BP units/mg. Heparin 
by-products from beef lung were fractionated with 
cetylpyndinmm (CP) chloride as in [ 1 l] CP-com- 
plexes obtamed between 1 .O and 1.2 M NaCl were 
recovered. 
Antrcoagulant activity was measured by the 
Pntchard modrfication of the USP procedure [121. 
Total uranic acid was determined with the 
carbazole [131 and orcmol methods [141. GIduronic 
and D-glucuromc acid was estimated by ton-exchange 
chromatography [lo] after acid hydrolysis, deaminatrve 
cleavage and rehydrolysrs [ 151 
Periodate oxidation was carried out as m [lo]. 
Two condrtrons were used: pH 3.0 and 4°C when 
D-glucuromc acid 1s selectively oxrdrzed and pH 7.0 
and 37°C when all non-sulphated uromc aads are 
oxidrzed. Oxyheparms were either reduced with 
sodmm borohydnde or cleaved by alkaline hminatron 
1161. 
Solvolytrc N-desulphatron was carned out as in 
[ 171. N-Acetylatron and N-sulphatron were performed 
by the methods m [ 181, [ 191, respectively 
Erg.1 Uromc acrd content (o) and anhcoagulant activity 
(0) of heparm after (a) periodate oxidation at pH 3.0 and 
4°C (- - - - - -) and (b) periodate oxidation at pH 7.0 and 
37°C (- ) The destruction of uranic acids was 
monitored by carbazole measurements Oxyheparins were 
reduced prior to broassay. The values are expressed as the 
percentage of zero-time controls 
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Table 1 
Uranic acrd composition, anticoagulant activrty and perrodate susceptrbility of heparins 
Samplea Uromc acidb Antrcoagulant Destructron of uromc acrdC 
activity 
IdUA GlcUA at pH 3,4’C at pH 7,3?C 
(%) (%) (BP units/mg) (%) (%) 
Heparm (H) 75 (80) 25 (20) 157 20 30 
H-P13(0h)-Red 120 
H-P13(3h)-Red 111 
H-P13(3h)XIH (93) ( 7) 100 
H-P13(6h)-Red 100 
HP1 3 (6h)-OH 86 
HP13(24h)-Red 95 5 64 
H-P13(24h)-OH 30 
H-NdeSO, 
H-NdeSO,-N-AC >95 <5 -Id 2: ;: 
H-NdeSO,-N-reSQ 104 20 30 
H-N-deSO,-P13(3h)-OH-N-reS0, 10 
HBP-(1.0-1.2) 50 50 88 30 55 
HBP-(1.0-1 2)-P13(3h)-OH 15 
a Abbrevzatrons P13 and P17, penodate oxrdatron at pH 3 0 and 4°C and pH 7 0 and 37’C, respectrvely (tmre 
of oxidation within parenthesis), Red, reduction with borohydride, OH, alkaline cleavage, N-deSO,, 
N-desulphated, N-reSO,, N-resulphated, N-AC, N-acetylated, HBP (1 O-1.2), heparm by-products obtamed as 
CP-complex between 1 0 and 1 2 M NaCl 
b Uranic acrd composition (IdUA, L-rduromc acrd, GlcUA- D-glucuromc acid) was determined after hydrolyses, 
deammatrve cleavage and rehydrolysrs followed by ion-exchange chromatography. Values obtamed m thus way 
correlate welJ wrth the carbazole-to-orcmol ratios (L.-i F., unpubhshed observations) Uromc acid contents 
calculated from c/o ratios are grven wrthin parentheses The two methods are probably accurate wrthm f 5% 
c Periodate oxidation was performed at pH 3 0 and 4°C (selective oxrdatron of D-glucuronic acid) and at pH 7 0 
and 37’C (oxrdation of all non-sulphated uromc acrds) Destructton of uranic acid was monitored by carbazole 
measurements 
d Accordmg to other reports [ 171 complete N-desulphation destroys the antrcoagulant activity of heparm 
e Periodate oxidation of N-desulphated heparm at elevated temperatures causes extensrve rosion of the 
molecule by cleavage of both the C(2)-C(3) bond of glucosamine with concomitant release of NH, and the 
C(2)-C(3) glycol m non-sulphated uromc acids (L -A F , unpublished observatrons) Presumably, other 
penodate-sensitrve sites appear after the initral attack 
conditions caused negligible reduction of antrcoagulant 
activity. When alI of the susceptible residues had been 
oxidized (after 3 h) 90% of the activity was retained. 
In contrast, oxidation of all non-sulphated uromc 
acid residues (D-glucuromc as well as L-iduromc acid) 
completely abolished the anticoagulant activity 
(fig.lb). These results were obtained with samples 
that had been reduced with borohydnde prior to 
assay. When oxidation at pH 3 .O and 4°C was followed 
by cleavage m alkaline medium the anticoagulant 
activity decreased shghtly (table 1). However, 
prolonged oxidation (24 h) reduced the activity 
considerably. 
Although oxidation of D-glucuromc acid at pH 3 .O 
and 4°C appears to be complete after 3-6 h (fig. la) 
the possibility remains that a few critical residues 
were oxuhzed at a slower rate. However, oxidation 
for 3 h and 24 h, respectrvely, followed by scission in 
alkah yielded mater& with identical elution profiles 
on Sephadex G-50 (fig.2a). 
Periodate oxidation at pH 3.0 and 4°C selectively 
oxidizes D-glucuromc acid associated with N-acetyl- 
glucosamme whrle D-glucuromc acid associated with 
N-sulphated glucosamme may be resistant [lo]. To 
mvestrgate whether D-glucuromc acid in the latter 
combmatron m hepann was resistant to oxidation at 
low pH and temperature, N-desulphated and 
N-acetylated heparin was subjected to oxidation and 
121 
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degradation. The extent of oxadataon (~20%, 
table 1) and the elution profile after cleavage (fig.2b) 
were the same as those obtained for the original 
material. Thus, periodate-resastant D-glucuromc acad 
residues were not present m this heparin preparation. 
EstamaUons of the uromc acid composition of 
periodate-oxadazed (pH 3.0 and 4°C) heparins also 
comfirmed that most, af not all, of the D-glucuromc 
acad residues were destroyed (table 1). 
Oxadataon and cleavage of D-glucuromc acad 
resadues mheparin resulted in a slight decrease in 
molecular saze (fig. 1 a)but retentaon of biological 
activity. In contrast, oxidaUon and cleavage of all 
non-sulphated uronic acids 0ncluding L-iduromc acid, 
table 1) which destroyed the antacoagulant ac avaty 
produced a more pronounced fragmentation f the 
molecule (fig.2c). However, m both cases the bulk of 
the fragments are estimated to be larger than 
dodecasacchande. 
In a study of L-iduronate ring conformations m 
desulphated heparins itwas dascovered that L-iduromc 
acid m the 4Ca and 1S3 conformers were sus- 
ceptible to penodate at pH 3.0 and 4°C provided 
adjacent glucosamme r sidues had free amino groups, 
wtule L-aduromc acid resadues in the 1C4 chaar were 
resastant [20]. In completely N-desulphated hepann 
which has lost its anticoagulant activity [17] 25% of 
the uromc acad residues were suscepUble to oxadatlon 
(table 1). After further cleavage m alkah and sub- 
sequent N-resulphation the actavaty remained low. In 
a control preparation ofhepann that was N-desulphated 
and N-resulphated activaty was restored. The frag- 
ments obtained after oxadataon and cleavage of 
N-desulphated heparm were consaderable smaller 
(fig.2d) than were those obtained after degradataon f
intact heparin (fig.la). In fact, the elutaon profile was 
samilar to that observed wath heparm that had been 
oxlchzed at pH 7.0 and 37°C followed by alkaline 
elimmataon (fig.2c). 
A heparin by-product with apprecaable antico- 
agulant actavaty (88 BP umts/mg) and an L-lduronic 
acad-to-D-glucuromc acad ratao f 1.1 was also oxidized 
at low pH and temperature for 3 h followed by 
alkaline cleavage. In this case the actwity was reduced 
to 15 BP units/mg. 
4. Discussion 
The results of the present study show that most, if 
not all, of the D-glucuromc acid residues of hepann 
can be oxadlzed without appreciable oss of antico- 
agulant activity. In contrast, oxadation ofnonsulphated 
L-iduromc acid residues destroys the activity. Oxada- 
tlon and subsequent reduction does not affect he 
chain length. Therefore xt may be proposed that non- 
sulphated L-lduromc acid residues are critical structural 
elements of an 'active site' m heparin. 
After oxidation and cleavage of D.glucuromc acid 
resadues the hepann fragments obtained still retained 
tugh anticoagulant actavity. However, m certain 
hepann by-products with a high D-glucuronic acad 
content the actavaty was lost after fragmentataon of 
the molecule. Ttus suggests hat although D-glucuromc 
acad residues are not essentaal e ements of 'active 
sltes' they may be intercalated between various ites 
(e.g., sites for thrombm and antithrombin III). 
Non-sulphated L-iduromc acad in heparin is likely 
to adopt 2 or 3 different ring confonnaUons [20]. 
D-Glucuronic acid-like conformers (4C1 and IS3) of 
L-iduromc acid seem to be part of an 'active sate' m 
heparin since oxidataon and cleavage of such residues 
destroys the antacoagulant activity. The collective 
experaence an the field [1-9] has suggested a partlca- 
patlon of both sulphated and non-sulphated Laduromc 
acad resadues mthe hepann-antithrombm b dmg 
sate. The present results trongly favour this idea. 
Since non-sulphated L-aduronic acad resadues are 
conformataonaUy versatile [20] the possabihty 
exasts that the catalyttc function of heparm m the 
antithrombm-thrombin reactaon isexerted vm altera- 
taons in the nng shape of L-iduronic acid. 
Prolonged oxadation (24 h) of heparm at low pH 
and temperature markedly reduced the antacoagulant 
potency. It is possable that side-reactaons of penodate 
(products of periodate and citrate, J. E. Scott, 
personal communicataon) r alterations of L-iduronate 
nng shapes are causing this effect. 
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